Holding(s) in Company

IP2IPO Group PLC
02 December 2005


                   NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of listed company

IP2IPO Group plc ('the Group')

2. Name of shareholder having a major interest

UBS AG

3. Please state whether notification indicates that it is regarding the holding
of the shareholder named in 2 above; in respect of a nonbeneficial interest; or
in the case of an individual holder if it is a holding of that person's spouse
or children under the age of 18

UBS AG has an interest in the Group's shares through its business and
legal entities UBS AG London Branch and UBS Global Asset Management
Life Ltd.

4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them

UBS AG London Branch - 1,788,748 ordinary shares representing 3.91% of
the then issued share capital of the Group
UBS Global Asset Management Life Ltd - 992,231 ordinary shares
representing 2.17% of the then issued share capital of the Group

5. Number of shares / amount of stock acquired

Not disclosed

6 Percentage of issued class (any treasury shares held by the listed company
should not be taken into account when calculating percentage)

Not disclosed

7. Number of shares / amount of stock disposed

nil

8 Percentage of issued class (any treasury shares held by the listed company
should not be taken into account when calculating percentage)

nil

9. Class of security

10p ordinary shares

10. Date of transaction

not disclosed
11. Date listed company informed

2 December 2005

12. Total holding following this notification

2,780,979 ordinary shares

13. Total percentage holding of issued class following this notification (any
treasury shares held by the listed company should not be taken into account when
calculating percentage)

6.08%

14. Any additional information

Nil

15. Name of contact and telephone number for queries

Alan Aubrey 020 7489 5200

16. Name and signature of duly authorised officer of the listed company
responsible for making this notification

Alan Aubrey

Date of notification

2 December 2005

The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.



                      This information is provided by RNS
            The company news service from the London Stock Exchange